Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) ROCE %: -73.98% (As of Mar. 2026)


BSP:ONCO3 Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
43 GF Score
Price R$1.09
GF Value R$3.49
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Oncoclinicas Do Brasil Servicos Medicos ROCE %?

Oncoclinicas Do Brasil Servicos Medicos BSP:ONCO3 -11.38% 43 ROCE % is -73.98% as of Mar. 2026. GuruFocus rates BSP:ONCO3 with a GF Score™ of 43/100 and a GF Value™ of R$3.49 (Possible Value Trap). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Oncoclinicas Do Brasil Servicos Medicos's annualized ROCE % for the quarter that ended in Mar. 2026 was -73.98%.

Oncoclinicas Do Brasil Servicos Medicos  (BSP:ONCO3) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Oncoclinicas Do Brasil Servicos Medicos ROCE % Related Terms

Oncoclinicas Do Brasil Servicos Medicos ROCE % Historical Data

* Premium members only.

The historical data trend for Oncoclinicas Do Brasil Servicos Medicos's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncoclinicas Do Brasil Servicos Medicos ROCE % Chart

Oncoclinicas Do Brasil Servicos Medicos Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 6.01 9.27 12.59 -0.68 -47.32

Oncoclinicas Do Brasil Servicos Medicos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.04 1.63 -100.55 -101.77 -73.98
BSP:ONCO3
43GF Score
Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncoclinicas Do Brasil Servicos Medicos ROCE % Calculation

Oncoclinicas Do Brasil Servicos Medicos's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-2526.368/( ( (11202.332 - 2453.206) + (7130.514 - 5201.94) )/ 2 )
=-2526.368/( (8749.126+1928.574)/ 2 )
=-2526.368/5338.85
=-47.32 %

Oncoclinicas Do Brasil Servicos Medicos's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-1212.616/( ( (7130.514 - 5201.94) + (6699.638 - 5350.118) )/ 2 )
=-1212.616/( ( 1928.574 + 1349.52 )/ 2 )
=-1212.616/1639.047
=-73.98 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -73.98% mean?
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) has a ROCE % of -73.98% as of Mar. 2026.
Is Oncoclinicas Do Brasil Servicos Medicos' ROCE % too high?
Oncoclinicas Do Brasil Servicos Medicos' current ROCE % is -73.98%. Overall, Oncoclinicas Do Brasil Servicos Medicos has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oncoclinicas Do Brasil Servicos Medicos' ROCE % compare to HCA and THC?
Oncoclinicas Do Brasil Servicos Medicos' ROCE % of -73.98% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.42, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncoclinicas Do Brasil Servicos Medicos's current ROCE % is -73.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoclinicas Do Brasil Servicos Medicos stock overvalued right now?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$3.49, compared to a current price of R$1.09 — trading 68.8% below its estimated fair value. The current ROCE % is -73.98%. Oncoclinicas Do Brasil Servicos Medicos' overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3), the current ROCE % is -73.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Overvalued in 2026?

Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos stock appears to be undervalued. The current stock price of R$1.09 is trading 68.8% below its estimated GF Value™ of R$3.49. GuruFocus considers Oncoclinicas Do Brasil Servicos Medicos to be Possible Value Trap.

Key valuation signals for BSP:ONCO3:

  • ROCE %: -73.98%
  • GF Value™: R$3.49 vs. price of R$1.09 (68.8% below fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the BSP:ONCO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncoclinicas Do Brasil Servicos Medicos Business Description

Address Avenida Presidente Juscelino Kubitschek, No. 510, 2nd Floor, Vila Nova Conceicao, Sao Paulo, SP, BRA, 04543-906
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.
43GF Score

Get the complete analysis for BSP:ONCO3

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$1.09
Price
R$3.49
GF Value